[1]
|
Chiarella, A.M. and Lu, D. (2020) Epigenetic Control of a Local Chromatin Landscape. International Journal of Molec-ular Sciences, 21, Article No. 943. https://doi.org/10.3390/ijms21030943
|
[2]
|
Sarkar, R., Banerjee, S., Amin, S.A., et al. (2020) Histone Deacetylase 3 (HDAC3) Inhibitors as Anticancer Agents: A Review. European Journal of Medici-nal Chemistry, 192, Article ID: 112171.
https://doi.org/10.1016/j.ejmech.2020.112171
|
[3]
|
Lu, C., Paschall, A.V., Shi, H., et al. (2017) The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion. Journal of the National Cancer Institute, 109, djw283. https://doi.org/10.1093/jnci/djw283
|
[4]
|
Johansson, C., Velupillai, S., Tumber, A., et al. (2016) Structural Analysis of Human KDM5B Guides Histone Demethylase Inhibitor Development. Nature Chemical Biology, 12, 539-545. https://doi.org/10.1038/nchembio.2087
|
[5]
|
Dorosz, J., Kristensen, L.H., Aduri, N.G., Mirza, O., Lousen, R., Bucciarelli, S., Mehta, V., et al. (2019) Molecular Architecture of the Jumonji C Family Histone Demethylase KDM5B. Scientific Reports, 9, Article No. 4019.
https://doi.org/10.1038/s41598-019-40573-y
|
[6]
|
Hao, F. (2021) Systemic Profiling of KDM5 Subfamily Signa-ture in Non-Small-Cell Lung Cancer. International Journal of General Medicine, 14, 7259-7275. https://doi.org/10.2147/IJGM.S329733
|
[7]
|
Jim, M.A., Pinheiro, P.S., Carreira, H., Espey, D.K., Wiggins, C.L. and Weir, H.K. (2017) Stomach Cancer Survival in the United States by Race and Stage (2001-2009): Findings from the CONCORD-2 Study. Cancer, 123, 4994-5013.
https://doi.org/10.1002/cncr.30881
|
[8]
|
Taniyama, Y., Katanoda, K., Charvat, H., Hori, M., Ohno, Y., Sasazuki, S., et al. (2017) Estimation of Lifetime Cumulative Incidence and Mortality Risk of Gastric Cancer. Japanese Journal of Clinical Oncology, 47, 1097-1102.
https://doi.org/10.1093/jjco/hyx128
|
[9]
|
Janjigian, Y.Y., Sanchez-Vega, F., Jonsson, P., Chatila, W.K., Hechtman, J.F., Ku, G.Y., et al. (2018) Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. Cancer Discovery, 8, 49-58.
https://doi.org/10.1158/2159-8290.CD-17-0787
|
[10]
|
Pectasides, E., Stachler, M.D., Derks, S., Liu, Y., Maron, S., Islam, M., et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discovery, 8, 37-48.
https://doi.org/10.1158/2159-8290.CD-17-0395
|
[11]
|
Li, G., Kanagasabai, T., Lu, W., Zou, M.R., Zhang, S.M., Celada, S.I., Izban, M.G., Liu, Q., et al. (2020) KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis. Cancer Research, 80, 4633-4643.
https://doi.org/10.1158/0008-5472.CAN-20-0505
|
[12]
|
Li, L., Zhu, G., Tan, K., Jiang, L., Li, Y., Zhu, X., Lin, Z., Zhang, X., Chen, J. and Ma, C. (2022) CUX2/KDM5B/ SOX17 Axis Affects the Occurrence and Development of Breast Cancer. Endocrinology, 163, bqac110.
https://doi.org/10.1210/endocr/bqac110
|
[13]
|
Liu, J. and Nie, C. (2022) KDM5B Regulates the PTEN/PI3K/Akt Pathway to Increase Sorafenib-Resistance in Hepatocellular Carcinoma. Anticancer Drugs, 33, 840-849. https://doi.org/10.1097/CAD.0000000000001329
|
[14]
|
Guo, J.C., Liu, Z., Yang, Y.J., Guo, M., Zhang, J.Q. and Zheng, J.F. (2021) KDM5B Promotes Self-Renewal of Hepatocellular Carcinoma Cells through the mi-croRNA-448-Mediated YTHDF3/ITGA6 Axis. Journal of Cellular and Molecular Medicine, 25, 5949-5962. https://doi.org/10.1111/jcmm.16342
|
[15]
|
Zhao, X., Zhang, X., Zhang, X., Jiang, T., Zhai, J., Wang, H., et al. (2021) MiR-374b-5p Inhibits KDM5B-Induced Epithelial-Mesenchymal Transition in Pancreatic Cancer. American Journal of Cancer Research, 11, 3907-3920.
|
[16]
|
Zhang, Z.G., Zhang, H.S., Sun, H.L., Liu, H.Y., Liu, M.Y. and Zhou, Z. (2019) KDM5B Promotes Breast Cancer Cell Proliferation and Migration via AMPK-Mediated Lipid Metabolism Reprogram-ming. Experimental Cell Research, 379, 182-190. https://doi.org/10.1016/j.yexcr.2019.04.006
|
[17]
|
Pu, Y., Xiang, J. and Zhang, J. (2020) KDM5B-Mediated microRNA-448 Up-Regulation Restrains Papillary Thyroid Cancer Cell Pro-gression and Slows down Tumor Growth via TGIF1 Repression. Life Sciences, 250, Article ID: 117519.
https://doi.org/10.1016/j.lfs.2020.117519
|
[18]
|
Kuo, K.T., Huang, W.C., Bamodu, O.A., Lee, W.H., Wang, C.H., et al. (2018) Histone Demethylase JARID1B/ KDM5B Promotes Aggressiveness of Non-Small Cell Lung Cancer and Serves as a Good Prognostic Predictor. Clinical Epigenetics, 10, Article No. 107. https://doi.org/10.1186/s13148-018-0533-9
|
[19]
|
Zhang, H., Liu, X., Chen, Y., Xu, R. and He, S. (2022) KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma. BioMed Research International, 2022, Article ID: 1556485.
https://doi.org/10.1155/2022/1556485
|
[20]
|
Mocavini, I., Pippa, S., Licursi, V., Paci, P., Trisciuoglio, D., Manni-roni, C., Presutti, C. and Negri, R. (2019) JARID1B Expression and Its Function in DNA Damage Repair Are Tightly Regulated by miRNAs in Breast Cancer. Cancer Science, 110, 1232-1243. https://doi.org/10.1111/cas.13925
|
[21]
|
Zhou, J., Yi, Q. and Tang, L. (2019) The Roles of Nuclear Focal Adhesion Kinase (FAK) on Cancer: A Focused Review. Journal of Experimental & Clinical Cancer Research, 38, Article No. 250.
https://doi.org/10.1186/s13046-019-1265-1
|
[22]
|
Fattahi, S., Amjadi-Moheb, F., Tabaripour, R., Ashrafi, G.H. and Akhavan-Niaki, H. (2020) PI3K/AKT/mTOR Signaling in Gastric Cancer: Epigenetics and Beyond. Life Sciences, 262, Article ID: 118513.
https://doi.org/10.1016/j.lfs.2020.118513
|
[23]
|
He, H., Huang, J., Wu, S., Jiang, S., Liang, L., Liu, Y., et al. (2021) The Roles of GTPase-Activating Proteins in Regulated Cell Death and Tumor Immunity. Journal of Hematology & On-cology, 14, Article No. 171.
https://doi.org/10.1186/s13045-021-01184-1
|
[24]
|
Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., et al. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death. Cell, 149, 1060-1072. https://doi.org/10.1016/j.cell.2012.03.042
|
[25]
|
Wang, Y., Zheng, L., Shang, W., Yang, Z., Li, T., Liu, F., et al. (2022) Wnt/beta-Catenin Signaling Confers Ferroptosis Resistance by Targeting GPX4 in Gastric Cancer. Cell Death & Differentiation, 29, 2190-2202.
https://doi.org/10.1038/s41418-022-01008-w
|
[26]
|
Gu, R., Xia, Y., Li, P., Zou, D., Lu, K., Ren, L., Zhang, H. and Sun, Z. (2022) Ferroptosis and Its Role in Gastric Cancer. Frontiers in Cell and Developmental Biology, 10, Article ID: 860344. https://doi.org/10.3389/fcell.2022.860344
|
[27]
|
Nagamori, I., Kobayashi, H., Nishimura, T., Yamagishi, R., Katahira, J., Kuramochi-Miyagawa, S., Kono, T. and Nakano, T. (2018) Relationship between PIWIL4-Mediated H3K4me2 Demethylation and piRNA-Dependent DNA Methylation. Cell Reports, 25, 350-356. https://doi.org/10.1016/j.celrep.2018.09.017
|
[28]
|
Wong, P.P., Miranda, F., Chan, K.V., Berlato, C., Hurst, H.C. and Scibetta, A.G. (2012) Histone Demethylase KDM5B Collaborates with TFAP2C and Myc to Repress the Cell Cycle Inhibitor p21(cip) (CDKN1A). Molecular and Cellular Biology, 32, 1633-1644. https://doi.org/10.1128/MCB.06373-11
|
[29]
|
Li, Y., Chen, L., Feng, L., Zhu, M., Shen, Q., Fang, Y., Liu, X. and Zhang, X. (2019) NEK2 Promotes Proliferation, Migration and Tumor Growth of Gastric Cancer Cells via Regulating KDM5B/H3K4me3. American Journal of Cancer Research, 9, 2364-2378.
|
[30]
|
Maruhashi, T., Sugiura, D., Okazaki, I.M. and Okazaki, T. (2020) LAG-3: From Molecular Functions to Clinical Applications. The Journal for ImmunoTher-apy of Cancer, 8, e001014. https://doi.org/10.1136/jitc-2020-001014
|